Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. On our ...

Weeks of teasers on social media noting that “Something big is coming. And it’s small,” have sparked a guessing game (and some patent searching) among NGS aficionados. But today, Illumina quelled the ...

Focused power on the MiSeq i100 System Access focused applications such as targeted resequencing, metagenomics, small genome sequencing, targeted gene expression profiling, and more. MiSeq i100 ...

The two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus Systems, will empower customers to unlock powerful insights through an affordable, comprehensive solution that is simple to understand ...

Illumina, Inc. (ILMN), a major developer of life science tools for large-scale genetic analysis, has launched MiSeq FGx Forensic Genomics System, the first fully approved next-generation (NGS) system ...

Oct 9 (Reuters) - Medical equipment maker Illumina (ILMN.O), opens new tab announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to ...

The MiSeq FG x ® Forensic Genomics Solution available from Verogen is the first-ever fully validated sequencing workflow developed exclusively for human identification applications (Figure 1). Thanks ...

It happens in Hollywood and on Broadway: Sometimes a great production wins mostly positive reviews from the critics but fails to wow the audience. The critics here are analysts, who largely applauded ...

SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, unveiled its MiSeq i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance ...